Patent Assignment
Reel/Frame 056639/0445
Assignment of Assignor's Interest
Recorded: 2021-06-23
Pages: 12
Assignors
REICH, SIEGFRIED H.
Executed: 2021-04-22
SPRENGELER, PAUL A.
Executed: 2021-04-27
WEBBER, STEPHEN E.
Executed: 2021-04-26
XIANG, ALAN X.
Executed: 2021-04-26
ERNST, JUSTIN T.
Executed: 2021-05-05
BORER, BENNETT C.
Executed: 2021-04-22
SPERRY, SAMUEL
Executed: 2021-04-22
WILSON, JO ANN Z.
Executed: 2021-04-26
Assignee
EFFECTOR THERAPEUTICS, INC.
11120 ROSELLE STREET, SUITE A, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(2)
Crystalline Forms of Mnk Inhibitors
Patent:
11,130,757 →
Application:
16/661,507 →
Publication:
US 2020/0131179
PCT:
PCT/US2019/057656 ↗
Crystalline Forms of Mnk Inhibitors
Application:
62/749,820 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 25, 2024
From: EFFECTOR THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 068086/0538 →
Assignment of Assignor's Interest
Feb 19, 2026
From: OXFORD FINANCE LLC; EFFECTOR THERAPEUTICS, INC.
To: SJP BIOTEC GMBH
Reel/Frame 074939/0717 →
Assignment of Assignor's Interest
Feb 20, 2026
From: OXFORD FINANCE LLC; EFFECTOR THERAPEUTICS, INC.
To: SJP BIOTEC GMBH
Reel/Frame 074946/0177 →